Healthcare Newsletter – December 2022 Edition
This edition of the JSA Healthcare Newsletter covers recent notifications and orders issued by the Ministry of Health and Family Welfare, Central Drugs Standard Control Organisation, Department of Pharmaceuticals. Some of the significant developments include:
- Registration of medical devices testing laboratories;
- Inspection/audits of pharmacovigilance system of importers and manufacturers of human vaccine;
- Joint inspection of drug manufacturing units for compliance under the Drugs and Cosmetics Act, 1940 and rules thereunder; and
To read further details, click here or refer to the below document.
For more details, please contact [email protected]
*In case the document is not visible on the device you are using, please click the link above.
